The 30th Asia -Pacific Academy of Ophthalmology Fair Summery

The 30th Asia -Pacific Academy of Ophthalmology Congress & the 20th Congress of the Chinese Ophthalmological Society was held on April 1st to 4th in Guangzhou, China.
We had received a lot of famous ophthalmologists from U.S.A, Italy, Oman, South Korea, Turkey, India, Pakistan, Malaysia and etc. Most of them were impressed by our innovative product to treat dry eye- Lacrimal Ductule Blocking Core(BC) and the Foldable Capsular Vitreous Body(FCVB) to save eye ball. Some customers even showed certain cooperation intention to us. We received high compliment from those customers.
We were negotiating the initial cooperation plan with Italian customers who have visited us for twice for our FCVB and BC.

The ophthalmologist from Omani showed great interested in our BC and identified an initial cooperation intention with us.

The Invitation To Asia-Pacific Vitreo-retina Society Congress 2017

Dear Honorable Customers:
The 11th Asia-Pacific Vitreo-retina Society (APVRS) Congress will take place on 8th -10th December 2017 in Kuala Lumpur Convention Centre, Malaysia. We are excited to announce our presence at the APVRS, demonstrating our innovative product The foldable Capsular Vitreous Body which is used to treat severe retinal detachment and can save eyeball.
The APVRS annual congress is the largest retinal meeting in the Asia-Pacific region which is the leading society representing the retinal specialist in the Asia-Pacific region, this meeting will have more than 100 top retinal experts from all over the world sharing their knowledge with more than thousands expected delegate which made the meeting of great quality.
We hereby sincerely invite you and your company representatives to visit our booth. The detail are as following:
City: Kuala Lumpur, Malaysia
Venue: Kuala Lumpur Convention Centre
Date: 8th -10th December 2017
Booth No.: 13
APVRES website: http://2017.apvrs.org/
It would be our great pleasure to meet you at the exhibition. Please kindly reply directly to this E-mail (info@vesber.com) to schedule our meeting.
Should you need any help, please feel free to contact us.
Wish you have a wonderful experience at APVRS and we are looking forward to your coming.
Guangzhou Vesber BiotechnologyCo.,Ltd
Addr: B501, No.1, Kesheng Road, Guangzhou Private Science and Technology Park, No.1633, Beitai Road, Baiyun District, Guangzhou, Guangdong, 510540, China
Tel: +86 20-36297899
FAX: +86 20-61165996
Web: www.vesber.com

The First Lessons About Implantation Of FCVB Successful

To spread and popularize this new technology safe and effective, Autek China INC.has held the first lessons about implantation of FCVB successful.There were about 40 experts of ocular trauma and ocular fundus diseases participating it.

Dr.Gao, the inventor of FCVB and the deputy director、doctoral tutor’s 、chief physician and lead researcher of Zhongshan Ophthalmic Center of Sun Yat-sen University, speak from background and research ideas to product design and clinical Application and current application experience and feedback at home and abroad, which has brought a high practical value of a seminar, participating experts also conducted a lively discussion and experience sharing.

Under the guidance of professor Gao and experienced experts, the training of animal eye simulation was carried out from the preparation of FCVB capsular before surgery, the details of the implantation process and the observation of the anatomy of the capsular in the animal eye after implantation. A grouping of operations was carried out to discuss the key steps of the surgery and some potential issues, operational training and experience sharing.

Ophthalmic Drug Sustained Release Research Expert Forum & The Five-Year-Plan Meeting

The Ophthalmic Drug Sustained Release Research Expert Forum & The Five-Year-Plan Meeting, organized by State Key Laboratory, Zhongshan Ophthalmic Center of Sun Yat-sen University was hold in Guangzhou YuXi Academy on Dec.27th, 2014. Ophthalmologists across the country were invited to give an academic presentation and post about the program of The Five-YearPlan progress. Being the subject of ophthalmic Drug Sustained Release undertaking unit, Guangzhou Vesber Biotechnology Co.,Ltd. carried on in-depth discussions with the ophthalmologists.
The meeting was started with the opening speech from Dr.Lin, the chairman of Zhongshan Ophthalmology Center of Sun Yatsen University. Tao He, the chairman of Hangzhou Medical Device Institute described the latest medical devices related knowledge and industry status. The vice president of Wenzhou Medical College, Professor Shen demonstrated an academic speech about the application of triamcinolone acetonide in the eye. Being the core leader in ophthalmology, Dr.Hui gave a lecture about the prevention and treatment of diabetic retinopathy. Dr.Yang from Northwest University, Mr.Wu from Guangzhou G&G Cataract Lens Co.,Ltd and Prof. Xie from Zhongshan Ophthalmology Center of Sun Yat-sen University proceeded with academic lectures and discussion.
The peribulbar drug release system, jointed developed by Zhongshan Ophthalmology Center of Sun Yatsen University and Guangzhou Vesber Biotechnology Co..Ltd. has received high evaluation from all the experts.
The advantage is that it will not destroy the eye ball structure while implantation as well as physical release without changes the medicine property. And the medicine could be complemented through drainage valve. The mould sharp could be changed in order to meet the diseased region demand.

Foldable Capsular Vitreous Body has approved for market launch in China

Recently, the Chinese CFDA approved the registration of the innovative medical product-Foldable Capsular Vitreous Body which is manufactured by Guangzhou Vesber Biotechnology Co.,Ltd.
This product is made from medical grade silicone rubber and consist of capsular, drain valve and drain tube. By injecting silicone rubber into the tailor-made mould, and deal with high temperature and high pressure to shape the capsular, drain valve and drain tube. It is used to treat patient with severe retinal detachment which can not be treated by the existing vitreous substitutes.
It first proposed the new theory of mimic the natural vitreous body and a new concept of artificial vitreous body, that is to simulate the shape of human’s natural vitreous cavity and designed to a solid foldable capsular vitreous body, thus to realize the long term stability of retinal supporting. The product is independently developed by our country, and be an international initiative product. It can be long-term filled in the eye, solved many difficult problems such as the vitreous substitutes can not long-term stayed in the eye, can not long-term support retina, and need repeated operation, etc. Hence, it can avoid the enucleation of eyeball and implant ocular prosthesis.
The State Food and Drug Administration will strengthen the supervision after this product launch to ensure the safety of medical device.

阅读更多

The Asia-Pacific Vitreo-Retina Society Meeting Fair Summary

The 11th Asia-Pacific Vitreo-Retina Society Meeting(APVRS) was held in Kuala Lumpur, Malaysia. On DEC 8-10. We had received a lot of famous ophthalmologists from Malaysia, Sri Lanka, Thailand, Turkey, Pakistan, HongKong, Taipei, Philippines, India, New Zealand and Australia etc. Most of the customers were impressed by our innovative product – Foldable Capsular Vitreous Body which is used to treat severe retinal detachment that cannot be treated by current vitreous substitutes, and can save eyeball. It is recommended as an intermediate product for use between silicone oil and ocular prosthesis. Some customers showed certain cooperative intention to us and want to have clinical study of our product, such as the ophthalmologists from Malaysia, Pakistan, Indonesia, Turkey etc. We received high compliment from these customers.

We were discussing with the doctor from Pakistan and he wants to cooperate with us to do the FCVB clinical study in Pakistan.